PP
TFFP

PDT Partners’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

PDT Partners’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-682
Closed -$96K – 1134
2022
Q2 		$96K Sell
682
-63
-8% -$8.79K 0.01% 887
2022
Q1 		$117K Sell
745
-338
-31% -$54.6K 0.01% 856
2021
Q4 		$240K Sell
1,083
-249
-19% -$48.2K 0.02% 732
2021
Q3 		$257K Buy
1,332
+845
+174% +$179K 0.02% 633
2021
Q2 		$117K Sell
487
-1
-0.2% -$274 0.01% 753
2021
Q1 		$166K Buy
+488
New +$198K 0.01% 717

Other funds holding TFFP

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sepio Capital Salt Lake City, Utah $1.84B AUM 18.57% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

PDT Partners's TFFP Position: Q3 2022 in Review

PDT Partners sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q3 2022, closing a stake of 682 shares — an estimated $96K sold.

PDT Partners first reported a position in TFFP in Q1 2021 and held it in 6 quarters. The position peaked at $257K in Q3 2021. 45 funds tracked by Wall St. Rank hold TFFP as of Q3 2022.

  • PDT Partners reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • PDT Partners sold 682 TFF Pharmaceuticals, Inc. Common Stock shares in Q3 2022, an estimated $96K.
  • PDT Partners first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • PDT Partners's TFF Pharmaceuticals, Inc. Common Stock position peaked at $257K in Q3 2021.
  • 45 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on PDT Partners's 13F filing for Q3 2022, filed 14 Nov 2022.